Skip global navigation and go to header navigation

Skip global navigation and read the article

Skip global navigation and go to local navigation

Skip global navigation and go to footer navigation



Home > Corporate Profile > Growth Strategy

Growth Strategy


Contents of page


Beyond Tomorrow

Extending Our Stage to the World
Since our establishment in 1955, Zeria Pharmaceutical Co., Ltd., guided by our corporate motto “Making health is making happiness,” has engaged in the research and development, production and marketing of pharmaceutical products, with Ethical Pharmaceuticals and Consumer Healthcare serving as the two pillars of our business operations.

Our ethical pharmaceutical drugs specialized in the gastrointestinal field and high-quality OTC drugs that support self-medication were born from the originality in each of these areas and a corporate strategy focused on our strengths.

Zeria’s stage for undertaking business is now extending to the entire world and we continuously take on challenges daily to support the future of patients who are fighting diseases as well as all those seeking health and beauty.

BALANCE

Well-balanced business portfolio consisting of the Ethical Pharmaceuticals and Consumer Healthcare businesses

Both of these two core businesses drive Zeria’s continuous growth by utilizing their respective strengths and contributing to earnings.

FOCUS

Intensively allocating management resources in our specialty fields

In the Ethical Pharmaceuticals business, Zeria is specialized in the gastrointestinal field from R&D to sales.
In the Consumer Healthcare business, we are developing products that contribute to self-medication (self-care).

GLOBAL

Global business development through alliances and M&A

By actively expanding global business development, our overseas sales to net sales ratio reached 51.5%.